Alabama Medicaid does cover Wegovy, but not for weight loss on its own. As of 2026, the state’s formulary lists Wegovy as “preferred with clinical criteria,” meaning a prescriber has to get prior authorization and the patient has to have one of three qualifying conditions: established cardiovascular disease with obesity or overweight, moderate to severe obstructive sleep apnea with obesity, or noncirrhotic MASH with moderate to advanced liver fibrosis.1Acentra Health / Alabama Medicaid. PA Instructions Apr 26
What Wegovy Is Covered For
Wegovy (semaglutide) is FDA-approved for chronic weight management, but Alabama Medicaid will not pay for it on that basis alone. Coverage is limited to three non-diabetes indications:1Acentra Health / Alabama Medicaid. PA Instructions Apr 26
- Cardiovascular risk reduction in adults with established cardiovascular disease who also have obesity or overweight.
- Obstructive sleep apnea in adults 18 or older with an apnea-hypopnea index of 15 or higher and a BMI of at least 30, without a diabetes diagnosis.
- MASH (metabolic-associated steatohepatitis) in patients with noncirrhotic disease at fibrosis stage F2 or F3, with obesity or overweight, and without a diabetes diagnosis.
Initial approval runs six months. After that, the prescriber has to seek reauthorization.1Acentra Health / Alabama Medicaid. PA Instructions Apr 26 The patient also has to be counseled on a reduced-calorie diet and increased physical activity, and Wegovy cannot be taken alongside another GLP-1 medication.2Acentra Health / Alabama Medicaid. PA Instructions Aug 25
What Alabama Medicaid Will Not Cover
If you are asking about Wegovy purely to lose weight and you do not have one of the three qualifying conditions above, Alabama Medicaid will not pay for it. Saxenda, another GLP-1 approved for weight management, is not covered at all.3Opelika Observer. Medicaid Now Covers GLP-1s for Obesity in Alabama Zepbound (tirzepatide) is covered only for obstructive sleep apnea and is explicitly excluded when prescribed for weight reduction without an OSA diagnosis.4Alabama Medicaid Agency. Preferred Drug List GLP-1s prescribed for type 2 diabetes, including Ozempic, Mounjaro, and Rybelsus, are a separate story: those are covered, also with clinical criteria and prior authorization.
How to Get It Approved
Every Wegovy prescription has to clear prior authorization before the pharmacy can fill it. The prescriber submits PA Form 369 with the drug name, strength, quantity, days supply, and clinical documentation supporting one of the qualifying indications.2Acentra Health / Alabama Medicaid. PA Instructions Aug 25
Wegovy falls into the incretin mimetics drug class, which Alabama runs through an electronic prior authorization system. At the pharmacy point of sale, the system checks the patient’s medical and claims history automatically. If the criteria are already documented, approval is issued on the spot. If not, the system sends the provider a message to submit a manual request online, by fax, or by mail. An electronic rejection at that stage is not a denial. It just means more documentation is needed.1Acentra Health / Alabama Medicaid. PA Instructions Apr 26
If the request is denied outright, the prescribing provider can ask for reconsideration using the PA Reconsideration (PAR) Form through the Alabama Medicaid Interactive Web Portal. Supporting documentation must be uploaded in PDF format, and faxed material has to travel with a system-generated barcode cover sheet tied to that specific PA number.5Alabama Medicaid Agency. PA Reconsideration Process
Why the Restrictions Exist
Federal law lets state Medicaid programs decide whether to cover drugs used for weight loss. Under the Medicaid Drug Rebate Program, states generally have to cover nearly all FDA-approved medications, but Congress carved out an exception for drugs used for “anorexia, weight loss, or weight gain.” States are still required to cover GLP-1 medications for other medically accepted indications, including type 2 diabetes, cardiovascular disease, and moderate to severe obstructive sleep apnea.6KFF. Medicaid Coverage of and Spending on GLP-1s Alabama’s Wegovy criteria track those required indications rather than extending coverage to obesity on its own.
Cost is why the line is drawn there. Monthly list prices for GLP-1s run roughly $1,000 to $1,350 before rebates or discounts.7Alabama Reflector. Biden Wanted Medicaid to Pay for Weight Loss Drugs, Trump Just Said It Doesnt Have To Alabama Medicaid spent $43.1 million on GLP-1 drugs in the 12 months ending October 2024, largely on diabetes prescriptions.3Opelika Observer. Medicaid Now Covers GLP-1s for Obesity in Alabama The practical takeaway for anyone hoping Wegovy will be covered: a prescriber has to be able to document cardiovascular disease, qualifying sleep apnea, or MASH, and then get prior authorization approved. A prescription written for weight loss alone will not be paid for.